复抗309药物与BCG对S180诱发肿瘤的作用
中图分类号:

R979.1 R73-36


Effects of FK309 Combined with BCG on Sarcoma 180 Cells-induced Tumor
  • 摘要
  • | |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • | |
  • 文章评论
    摘要:

    目的 研究化合药物与免疫增强剂联合应用对S1 80 肉瘤细胞的影响。方法 以皮下移植性S1 80 肉瘤细胞的昆明小鼠为荷瘤动物模型 ,用复抗 30 9和卡介苗 (BCG)联合应用于机体 ,然后进行血常规化验 ,血清生化分析 ,病理组织学观察及计算肿瘤生长抑制率。结果 实验组小鼠血清总蛋白和白蛋白高于对照组 ,组织学检查发现实验组小鼠的肿瘤坏死程度比对照组严重。第 5、10天及 15天时的抑瘤率分别是 14 3% ,2 1 4 %和 36 4 %。各组瘤重经统计学处理表明 ,第 5天及第 10天的瘤重差异无显著性 ,第 15天的瘤重差异有显著性 (P <0 0 5 )。实验小鼠的平均体重变化差异不显著。结论 BCG和复抗 30 9对肿瘤的发展有所抑制。

    Abstract:

    Objective To study the effects of chemical medicine combined with immunopotentiator on sarcoma 180 Cells.Methods Kunming mice were used as laboratory animal models which were all with sarcoma 180 cells transplanted subcutaneously. Test group was administered FK309 combined with BCG. Then the authors did the ordinary blood test and serumal biochemical test,observed pathological tissue slices,and calculated inhibition rate of the growth of tumor. Results Total protein and albumin of test group were higher than those of control group. Examination of tissue slices showed that necrotic degree of tumor of test mice was worse than that of controls. The inhibition rate of sarcoma on the fifth,tenth,fifteenth days was 14.3%, 21.4% and 36.4% respectively. Statistical assay indicated that there was no significant difference (P<0.05) between the mean weight of tumor of both groups until the fifteenth day(P<0.05) . The mean weight of mice had no conspicuous difference.Conclusion FK309 with BCG may be of value in the inhibition of the development of tumors.

    参考文献
    相似文献
    引证文献
引用本文

王传武,阳继兵,赵德明,秦秀慧.复抗309药物与BCG对S180诱发肿瘤的作用[J].中国比较医学杂志,2003,(4):193~196.

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 最后修改日期:2002-04-26
防诈骗提示!请勿点击不明链接或添加个人微信。编辑部所有邮箱后缀均为@cnilas.org
关闭